Is Amplify Weight Loss Drug & Treatment ETF a good dividend ETF?

Amplify Weight Loss Drug & Treatment ETF (THNR) is a dividend-paying ETF with a current dividend yield of 1.53%. Review its dividend history, payout consistency and growth to judge whether it fits your income strategy.

What is THNR's dividend yield?

The dividend yield for THNR ETF is currently 1.53%.

How much does THNR pay in dividends per year?

Amplify Weight Loss Drug & Treatment ETF pays an annual dividend of $0.4132 per share over the trailing twelve months.

How often does THNR pay dividends?

THNR ETF pays dividends annually.

THNR Stock Price, Chart, Stats & News

Amplify Weight Loss Drug & Treatment ETF

Save

Overview Dividends Holdings

Amplify Weight Loss Drug & Treatment ETF (THNR) is a dividend-paying ETF with a current dividend yield of 1.53% as of Sep 4, 2026. It pays $0.4132 per share over the trailing twelve months and distributes annually.

Health

THNR chart

Loading chart...

THNR returns

YTD	5.86%
1Y	18.36%
1Y volatility	15.04%
3Y volatility	0.00%
Sharpe ratio	0.00

About

The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals.

Top 10 THNR holdings

Holding	Ownership
Novo Nordisk A/S NVO NYSE	Health care 8.89%
Eli Lilly and Compa… LLY NYSE	Health care 8.61%
Regeneron Pharmaceu… REGN NASDAQ	Health care 6.02%
Scholar Rock Holdin… SRRK NASDAQ	Health care 5.69%
Amgen Inc. AMGN NASDAQ	Health care 5.59%
Merck & Company Inc MRK NYSE	Health care 5.48%
AbbVie Inc ABBV NYSE	Health care 5.11%
Pfizer Inc PFE NYSE	Health care 5.00%
Arrowhead Pharmaceu… ARWR NASDAQ	Health care 4.95%
Hims Hers Health Inc HIMS NYSE	Health care 4.58%